NEW YORK, Nov. 3 (GenomeWeb News) - Lion Bioscience reported a 42-percent year-over-year decline in revenues for its second fiscal quarter today, but the company's bioinformatics business -- which is in the process of being sold to an undisclosed buyer -- posted a profit for the first time in Lion's history.
Registering provides access to this and other free content.
Already have an account?Login Now.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.
Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.
In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.